日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Preclinical Evaluation of the Efficacy of α-Difluoromethylornithine and Sulindac Against SARS-CoV-2 Infection

α-二氟甲基鸟氨酸和舒林酸对抗SARS-CoV-2感染疗效的临床前评价

Ignatenko, Natalia A; Trinh, Hien T; Wagner, April M; Gerner, Eugene W; Bime, Christian; Hsu, Chiu-Hsieh; Besselsen, David G

Phase 1 study of high-dose DFMO, celecoxib, cyclophosphamide and topotecan for patients with relapsed neuroblastoma: a New Approaches to Neuroblastoma Therapy trial

一项针对复发性神经母细胞瘤患者的高剂量DFMO、塞来昔布、环磷酰胺和拓扑替康联合治疗的I期研究:一项神经母细胞瘤治疗新方法试验

Hogarty, Michael D; Ziegler, David S; Franson, Andrea; Chi, Yueh-Yun; Tsao-Wei, Denice; Liu, Kangning; Vemu, Rohan; Gerner, Eugene W; Bruckheimer, Elizabeth; Shamirian, Anasheh; Hasenauer, Beth; Balis, Frank M; Groshen, Susan; Norris, Murray D; Haber, Michelle; Park, Julie R; Matthay, Katherine K; Marachelian, Araz

GSTΠ stimulates caveolin-1-regulated polyamine uptake via actin remodeling

GSTΠ通过肌动蛋白重塑刺激caveolin-1调节的多胺摄取

Uemura, Takeshi; Tsaprailis, George; Gerner, Eugene W

Cancer pharmacoprevention: Targeting polyamine metabolism to manage risk factors for colon cancer

癌症药物预防:靶向多胺代谢以控制结肠癌风险因素

Gerner, Eugene W; Bruckheimer, Elizabeth; Cohen, Alfred

Intermittent Dosing with Sulindac Provides Effective Colorectal Cancer Chemoprevention in the Azoxymethane-Treated Mouse Model

在偶氮甲烷处理的小鼠模型中,间歇性给予舒林酸可有效预防结直肠癌。

Chandra, Swati; Nymeyer, Ariel C; Rice, Photini Faith; Gerner, Eugene W; Barton, Jennifer K

Time-serial Assessment of Drug Combination Interventions in a Mouse Model of Colorectal Carcinogenesis Using Optical Coherence Tomography

利用光学相干断层扫描技术对小鼠结直肠癌模型中药物组合干预进行时间序列评估

LeGendre-McGhee, Susan; Rice, Photini S; Wall, R Andrew; Sprute, Kyle J; Bommireddy, Ramireddy; Luttman, Amber M; Nagle, Raymond B; Abril, Edward R; Farrell, Katrina; Hsu, Chiu-Hsieh; Roe, Denise J; Gerner, Eugene W; Ignatenko, Natalia A; Barton, Jennifer K

Combined benefit of prediction and treatment: a criterion for evaluating clinical prediction models

预测与治疗的综合获益:临床预测模型评价标准

Billheimer, Dean; Gerner, Eugene W; McLaren, Christine E; LaFleur, Bonnie

Clinical end points for developing pharmaceuticals to manage patients with a sporadic or genetic risk of colorectal cancer

用于开发治疗散发性或遗传性结直肠癌风险患者的药物的临床终点

Rial, Nathaniel S; Zell, Jason A; Cohen, Alfred M; Gerner, Eugene W

Role of obesity in a randomized placebo-controlled trial of difluoromethylornithine (DFMO) + sulindac for the prevention of sporadic colorectal adenomas

肥胖在二氟甲基鸟氨酸(DFMO)+舒林酸预防散发性结直肠腺瘤的随机安慰剂对照试验中的作用

Zell, Jason A; Lin, Bruce S; Madson, Nikki; McLaren, Christine E; Gerner, Eugene W; Meyskens, Frank L

Of timing and surrogates: a way forward for cancer chemoprevention

时机与替代指标:癌症化学预防的未来之路

Thompson, Patricia A; Gerner, Eugene W